NJ State Employees Deferred Compensation Plan’s Gilead Sciences GILD Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,760	Closed	-$1.19M	–	162
2025 Q3	$1.19M	Sell	10,760 -3,240	-23%	-$368K	0.13%	159
2025 Q2	$1.55M	Hold	14,000	–	–	0.18%	123
2025 Q1	$1.57M	Hold	14,000	–	–	0.2%	119
2024 Q4	$1.29M	Hold	14,000	–	–	0.16%	151
2024 Q3	$1.17M	Hold	14,000	–	–	0.14%	159
2024 Q2	$961K	Hold	14,000	–	–	0.12%	175
2024 Q1	$1.03M	Hold	14,000	–	–	0.13%	175
2023 Q4	$1.13M	Hold	14,000	–	–	0.16%	147
2023 Q3	$1.05M	Hold	14,000	–	–	0.16%	150
2023 Q2	$1.08M	Hold	14,000	–	–	0.16%	147
2023 Q1	$1.16M	Hold	14,000	–	–	0.18%	131
2022 Q4	$1.2M	Hold	14,000	–	–	0.19%	133
2022 Q3	$864K	Hold	14,000	–	–	0.15%	158
2022 Q2	$865K	Hold	14,000	–	–	0.14%	162
2022 Q1	$832K	Hold	14,000	–	–	0.11%	187
2021 Q4	$1.02M	Hold	14,000	–	–	0.13%	174
2021 Q3	$978K	Hold	14,000	–	–	0.13%	168
2021 Q2	$964K	Hold	14,000	–	–	0.13%	167
2021 Q1	$905K	Hold	14,000	–	–	0.13%	172
2020 Q4	$816K	Hold	14,000	–	–	0.13%	167
2020 Q3	$885K	Hold	14,000	–	–	0.16%	132
2020 Q2	$1.08M	Hold	14,000	–	–	0.2%	109
2020 Q1	$1.05M	Hold	14,000	–	–	0.24%	99
2019 Q4	$910K	Hold	14,000	–	–	0.15%	134
2019 Q3	$887K	Hold	14,000	–	–	0.16%	128
2019 Q2	$946K	Hold	14,000	–	–	0.17%	123
2019 Q1	$910K	Sell	14,000 -8,000	-36%	-$532K	0.17%	128
2018 Q4	$1.38M	Hold	22,000	–	–	0.29%	87
2018 Q3	$1.7M	Hold	22,000	–	–	0.29%	80
2018 Q2	$1.56M	Sell	22,000 -18,000	-45%	-$1.27M	0.28%	84
2018 Q1	$3.02M	Hold	40,000	–	–	0.54%	43
2017 Q4	$2.87M	Hold	40,000	–	–	0.5%	48
2017 Q3	$3.24M	Hold	40,000	–	–	0.59%	31
2017 Q2	$2.83M	Hold	40,000	–	–	0.53%	42
2017 Q1	$2.72M	Hold	40,000	–	–	0.52%	40
2016 Q4	$2.86M	Hold	40,000	–	–	0.57%	36
2016 Q3	$3.17M	Hold	40,000	–	–	0.65%	28
2016 Q2	$3.34M	Hold	40,000	–	–	0.71%	22
2016 Q1	$3.9M	Hold	40,000	–	–	0.83%	15
2015 Q4	$4.05M	Hold	40,000	–	–	0.83%	18
2015 Q3	$3.93M	Hold	40,000	–	–	0.85%	16
2015 Q2	$4.68M	Hold	40,000	–	–	0.91%	13
2015 Q1	$3.92M	Hold	40,000	–	–	0.76%	19
2014 Q4	$3.77M	Sell	40,000 -20,000	-33%	-$2.07M	0.74%	22
2014 Q3	$6.39M	Hold	60,000	–	–	1.3%	6
2014 Q2	$4.97M	Hold	60,000	–	–	0.98%	11
2014 Q1	$4.25M	Hold	60,000	–	–	0.87%	14
2013 Q4	$4.51M	Hold	60,000	–	–	0.92%	14
2013 Q3	$3.77M	Hold	60,000	–	–	0.82%	14
2013 Q2	$3.08M	Buy	+60,000	New	+$3.13M	0.7%	19

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's GILD Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 10,760 shares — an estimated $1.19M sold.

NJ State Employees Deferred Compensation Plan first reported a position in GILD in Q2 2013 and held it in 50 quarters. The position peaked at $6.39M in Q3 2014. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 10,760 Gilead Sciences shares in Q4 2025, an estimated $1.19M.
NJ State Employees Deferred Compensation Plan first reported a position in Gilead Sciences in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Gilead Sciences position peaked at $6.39M in Q3 2014.
2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.